Conditions for the occurrence of drug interactions during biotransformation
Grille, W.; Johnsen, K.; Kolenda, K.D.
Medizinische Klinik 74(3): 55-67
1979
ISSN/ISBN: 0025-8458 PMID: 83532 Document Number: 141116
Document emailed within 1 workday
Related Documents
Warrington, J.S.; Shader, R.I.; von Moltke, L.L.; Greenblatt, D.J. 2000: In vitro biotransformation of sildenafil (Viagra): identification of human cytochromes and potential drug interactions Drug Metabolism and Disposition: the Biological Fate of Chemicals 28(4): 392-397Klimova, E.A.; Timina, V.P. 1986: Probability of occurrence of undesirable effects of drug interactions in the treatment of suppurative meningitis Sovetskaia Meditsina 12: 119-121
Kohl, C.; Steinkellner, M. 2000: Prediction of pharmacokinetic drug/drug interactions from in vitro data: interactions of the nonsteroidal anti-inflammatory drug lornoxicam with oral anticoagulants Drug Metabolism and Disposition: the Biological Fate of Chemicals 28(2): 161-168
Estler, C.J. 1984: Drug interactions of central nervous system active drugs. 3: Drug interactions of anticonvulsants and antiparkinson agents Fortschritte der Medizin 102(6): 129-132
Andersson, M.L.; Böttiger, Y.; Lindh, J.D.; Wettermark, B.; Eiermann, B. 2013: Impact of the drug-drug interaction database SFINX on prevalence of potentially serious drug-drug interactions in primary health care European Journal of Clinical Pharmacology 69(3): 565-571
Kourounakis, P.N.; Rekka, E.; Hadjipetrou-Kourounakis, L. 1991: Restoration of impaired drug metabolism of rats with adjuvant induced disease by two steroids with different influence on drug biotransformation Die Pharmazie 46(10): 727-729
Bressler, R. 2005: Herb-drug interactions: interactions between ginseng and prescription medications Geriatrics 60(8): 16-17
Riska, P.; Lamson, M.; MacGregor, T.; Sabo, J.; Hattox, S.; Pav, J.; Keirns, J. 1999: Disposition and biotransformation of the antiretroviral drug nevirapine in humans Drug Metabolism and Disposition: the Biological Fate of Chemicals 27(8): 895-901
Cinti, D.L.; Schenkman, J.B. 1972: Hepatic organelle interaction. I. Spectral investigation during drug biotransformation Molecular Pharmacology 8(3): 327-338
Pathak, J.; Kiefer, R.C.; Chute, C.G. 2013: Using linked data for mining drug-drug interactions in electronic health records Studies in Health Technology and Informatics 192: 682-686
Kumar, S.; Rao, P.S.S.; Earla, R.; Kumar, A. 2015: Drug-drug interactions between anti-retroviral therapies and drugs of abuse in HIV systems Expert Opinion on Drug Metabolism and Toxicology 11(3): 343-355
Scarsi, K.K.; Darin, K.M.; Chappell, C.A.; Nitz, S.M.; Lamorde, M. 2016: Drug-Drug Interactions, Effectiveness, and Safety of Hormonal Contraceptives in Women Living with HIV Drug Safety 39(11): 1053-1072
Kellner, H.M.; Arnold, C.; Christ, O.E.; Eckert, H.G.; Herok, J.; Hornke, I.; Rupp, W. 1981: Pharmacokinetics and biotransformation of the antimycotic drug ciclopiroxolamine in animals and man after topical and systemic administration Arzneimittel-Forschung 31(8a): 1337-1353
Palmer, J.D.; Bressler, R. 1974: Drug--drug interactions. A general discussion about how and where drugs may interact in the body Arizona Medicine 31(2): 89-93
Plichta, D.; Doryńska, A.; Spiewak, R.ła. 2012: Patterns of drug consumption and the occurrence of adverse drug reactions among students of public health Polski Merkuriusz Lekarski: Organ Polskiego Towarzystwa Lekarskiego 32(190): 232-237
Wagner, J.G.; Weidler, D.J.; Lin, Y.J. 1976: New method for detecting and quantitating pharmacokinetic drug-drug interactions applied to ethanol-propranolol Research Communications in Chemical Pathology and Pharmacology 13(1): 9-18
Furue, H. 1986: Application and problems of combination drug therapy--drug interactions of antineoplastic agents and antibiotics Nihon Rinsho. Japanese Journal of Clinical Medicine 44(4): 942-946
Hensjö, L.O. 1995: A new classification introduced in Fass (Swedish Drug Index). a simple way for assessment of drug interactions Lakartidningen 92(38): 3479-3480
Kigen, G.; Kimaiyo, S.; Nyandiko, W.; Faragher, B.; Sang, E.; Jakait, B.; Owen, A.; Back, D.; Gibbons, S.; Seden, K.; Khoo, S.H.; Nyandiko, W.; Wools-Kaloustian, K.; Kimaiyo, S.; Braitstein, P.; Sang, E.; Jakait, B.; Pastakia, S. 2011: Prevalence of potential drug-drug interactions involving antiretroviral drugs in a large Kenyan cohort Plos one 6(2): E16800
Emilien, G.; Maloteaux, J.M. 1998: Pharmacological management of epilepsy. Mechanism of action, pharmacokinetic drug interactions, and new drug discovery possibilities International Journal of Clinical Pharmacology and Therapeutics 36(4): 181-194